Updated version 1 - PepsiCo will cut costs as weak North American business weighs on annual core profit outlook
路透社2026/10/08 10:26The third paragraph adds comments from the CEO, and the fourth paragraph provides information on stock price trends. Reuters, October 8 - PepsiCo (PEP.O) announced on Thursday that, due to weak snack and beverage demand in North America and rising input costs, it has lowered its annual core profit forecast and will further advance cost-cutting measures. Consumer goods manufacturers such as PepsiCo, General Mills (GIS.N), McCormick (MKC.N), and Conagra Brands (CAG.N) are facing a challenging operating environment: soaring raw material costs are squeezing profit margins, and rising gasoline prices are prompting consumers to be cautious with their spending, thereby dampening demand. “We are developing additional structural cost reduction measures, which will be implemented in the coming months to support investments aimed at accelerating organic revenue growth and mitigating the impact of input cost inflation,” CEO Ramon Laguarta stated in the announcement. The company’s shares rose about 1% in pre-market trading. The company expects that, after adjusting for currency fluctuations, fiscal 2026 core earnings per share will rise between 1% and 2%, lowered from the previous forecast of a 4% to 6% increase at the low end. In addition, the company expects annual organic revenue to grow by roughly 3%, compared to its previous forecast range of 2% to 4%. (For the convenience of non-English speakers, Reuters has automatically translated this report into several other languages. Automated translations may contain errors or may lack necessary context, and Reuters does not guarantee the accuracy of automated translation texts, which are provided for convenience only. Reuters accepts no liability for any damage or loss arising from the use of the automated translation feature.)
Added CEO comments in paragraph 3 and stock price movement in paragraph 4.
Reuters, October 8 - PepsiCo (PEP.O) said on Thursday that, due to weak demand for snacks and beverages in North America and rising input costs, it has lowered its annual core profit forecast and will further implement cost-cutting measures.
Consumer goods manufacturers such as PepsiCo, General Mills GIS.N, McCormick MKC.N and Conagra Brands CAG.N are facing challenging operating conditions: surging raw material costs are squeezing profit margins, while rising gasoline prices are making consumers more cautious, thereby dampening demand.
"We are formulating further structural cost reduction measures which will be implemented in the coming months to support investments aimed at accelerating organic revenue growth and mitigating the impact of input cost inflation," CEO Ramon Laguarta said in a statement.
The company's shares rose about 1% in pre-market trading.
The company expects core earnings per share, adjusted for currency fluctuations, to grow by 1% to 2% in fiscal year 2026, compared to a previous forecast of growth at the lower end of the 4% to 6% range.
In addition, the company expects annual organic revenue to grow by about 3%, compared to a prior forecast in the 2% to 4% range.
(To assist non-English speakers, Reuters has automatically translated its reporting into several other languages. Since automated translation may contain errors or lack context, Reuters does not guarantee the accuracy of the automated translation and provides it for readers' convenience only. Reuters accepts no responsibility for any damage or loss caused by the use of automated translation functions.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Analyst Gu Jingci: Follow the trend and adapt flexibly
XRP Ledger adds account control feature, enabling enterprises to manage assets offline.
BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals
October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)
Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low
UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.
Crypto prices
More
